Your Pipeline is moving forward. Is your GMP CAPACITY keeping up?
BRG Communication Lead II
IS YOUR GMP CAPACITY THE NEW CRITICAL PATH? GMP IS IN OUR DNA®
Biotech Resources Group (BRG) helps GMP biologics companies make better manufacturing decisions when it matters most—whether you need to Build new capacity, Optimize an existing facility, or Buy capacity from a CDMO partner.
If you’re here, it’s because inaction is not an option: you’re either building new capacity and wrestling with a high horsepower EPCM partner, trying to squeeze more safe, reliable throughput from an existing site, or navigating the risk and ambiguity of selecting and managing a DS/DP CDMO with confidence and governance.
Helping biotechnology companies make better manufacturing decisions at the moments that matter most—whether that’s green/brownfield facility and EPCM support, a hidden capacity and dysfunctional Ops Audit, or sponsor-side CDMO selection, award, and governance— the outcome is to turn complex GMP choices into practical next steps instead of costly hesitation.
CAPACITY IS THE NEW CRITICAL PATH?
BUILD ✦ OPTIMIZE ✦ BUY
The Decision
Three paths to capacity. One clear decision. One clear goal. Let's put Pencil-to-paper! Biotech Resources Group helps you choose the right path, or the right mix, and carry it out with GMP Rigor. BUILD: Create capacity you control. Facility strategy, design, engineering and readiness for new or expanded GMP operations, from concept through qualification and inspection readiness. OPTIMIZE: Get more from what you already have. Find and remove the hidden constraints in your current operations, including throughput, changeovers, quality systems, release and right-first-time performance, so you gain capacity without new walls. BUY: Secure capacity through the right partners. CDMO and supplier strategy, selection, due diligence and tech-transfer readiness, so outsourced capacity is reliable, compliant and aligned with your timelines. Most organizations don't need a single answer. Most need a capacity strategy that combines all three lanes at the right time. Let's connect.
SERVICE ECOSYSTEM: BRIDGEONE
3 Service Lanes: Build, Optimize, and/or Buy

  • BUILD

    BRG supports mature, medium-sized GMP biologics companies as they define, select, engage, score, award, and work with a large, high-horsepower design engineering (EPCM) partner. This service is focused on new facility builds, expansions, and post-acquisition site set-up. Since this is an independent lens, you'll have a voice at the table resulting in a project that is better aligned on capacity, process fit, cost, schedule, and long-term operability.

  • OPTIMIZE

    20-40% of your Design-Basis Capacity may be Hidden.
    We help mature biologics manufacturers pinpoint where their existing facility is losing throughput. We'll assess scheduling, contamination, quality systems, automation, staffing, operational dysfunction, and/or legacy design. Upside: Defer CAPEX or CDMO spend.

  • BUY

    CDMO Search, Score, Audit, Selection, Award & Sponsor-Side Management. BRG supports small/medium sized biologics companies as they search, RFI, audit, score, award, and manage a CDMO partner. This service cuts across most modalities and is designed to align program needs, requisite expertise, experience, and project governance. The result is a better-fit CDMO relationship with fewer technical, quality, schedule, and partnership surprises.

  • GMP ASSESSMENT

    GOAL#1: Close your capacity gap before it closes your success window.
     Take our free capacity assessment. In one risk-free step, we'll start to identify where your capacity risks are and which lane, Build, Optimize or Buy gets you to your goal in the best way. Let's use your resources in the wisest way possible. --------------------------- Assess Your Capacity here. Connect with a GMP Advisor.
image
image
mAb✦Cytokine✦Inclusion-body✦AAV✦LV CAR-T✦RLT✦ADC✦Antibiotics
"Resolving capacity-specific pain-points significantly lowers internal tension, fostering a more collaborative and productive work environment." - Susan & Bob Valdes
image
BRG: BY THE NUMBERS
FOUNDERS' EXPERIENCE: 50+ yr NETWORK'S COLLECTIVE EXPERIENCE: 200+ yr GMP DIVISION FOUNDED: 2011 RECRUITING DIVISION FOUNDED: 2000 PROJECT GEO: 6 CONTINENTS FACILITIES: 20+ MODALITIES: 5+ CDMO/INNOVATOR/HYBRID: ALL REQUISITE A.I. GOVERNANCE: YES
image
HOSTS: 4DS/DP: YesE-BOOKS: 2+PLAYBOOKS: 3SCI JOURNAL PAPERS: 1TRADEMARKS: 3 SERVICE LANES: 3 NETWORK: GLOBAL LANGUAGES: 6
Human Expertise Clear A.I. Boundaries
At Biotech Resources Group, you engage human expertise — not A.I.-generated reports. Our A.I. Use, Human Authorship & Content Integrity Policy requires qualified, named experts to develop every report’s framework, narrative, analysis, and recommendations. We permit approved A.I. tools only for defined support tasks, with disclosure and human verification, and prohibit entering confidential client information into tools not approved for that data classification. Sources are personally checked, authors remain accountable, and deliverables undergo documented review. For our clients, that means clear boundaries around A.I. use, safeguards for sensitive information, and advice grounded in professional judgment—not purely automated synthesis.
image
Our A.I. Policy document is shared after CDA execution.
image
image
image
© Copyright 2026 Biotech Resources Group, LLC ☎ -+1--617.858.033.two--- ☎ -+1--202.738.338.six--- GEO USA, EU, APAC WEB www.biotech-1.com 𐀪 Robert & Susan Valdes ✉ bobv@biotech-1.com 🏠︎1 Washington, D.C. Metro Area 🏠︎2 Boston Metro Area Build - Optimize - Buy © GMP IS IN OUR DNA® GMP IS IN OUR pDNA® GMP IS IN OUR mRNA®
image